Navigation Links
Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients
Date:4/24/2008

trategies: monitoring viral load and CD4 cell count or clinical observation.

Over a period of five years, 83 percent of patients using the viral load monitoring strategy, 82 percent using CD4 cell count monitoring, and 82 percent using clinical monitoring survived.

After a period of 20 years, survival rates were 67 percent, 64 percent and 64 percent, respectively. Viral load monitoring showed a slightly longer survival but was not the most cost-effective avenue (at a cost of around $3,500 per life-year gained).

Other experts were concerned that the results might be construed to mean viral load monitoring and CD4 cell count should be abandoned in the developed world.

"It's a great study, but it has no application to First World countries," said Dr. Michael Horberg, director of HIV/AIDS policy at Kaiser Permanente Health Plan in Santa Clara, Calif. "There is wide availability of these tests, and there should be funds to support such monitoring.

"Having said that, it has to be well-acknowledged that in resource-limited nations, CD4 count and viral load monitoring are expensive and have limited availability, and clinical decisions have to be made on the basis of clinical impressions," Horberg continued. "Health-care infrastructures must be sent to resource-limited nations. However, in the interim, clinicians should at least be reassured that their clinical practices are not doing undue harm.

"Infectivity seems to be increased with increased viral load. Not monitoring viral load could mean that highly infectious patients are passing the virus to new people and, indeed, a virus which is already resistant to drugs."

More information

The World Health Organization has more on antiretroviral therapy for HIV infection.



SOURCES: Andrew N. Phillips, Ph.D., professor, epidemiology
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cancer researchers receive NIH grant to advance brain tumor therapies from lab to clinical trials
2. Versus Technology, Inc. Announces Collaboration with Cleveland Clinic to Create Clinical Patient Flow Model
3. Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus
4. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
5. Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM
6. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
7. Siemens New Clinical Education Training Facility Opens Doors and Expands Offerings for Imaging Professionals
8. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
9. Clinical Trial Volunteers Uneasy About Some Financial Ties
10. Quintiles Ranks First in Pan-European Clinical Investigator Study
11. Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinical Symptoms Enough to Switch Drug Regimens for HIV Patients
(Date:7/30/2014)... WA (PRWEB) July 30, 2014 According to ... Vkool.com, this is a comprehensive bodybuilding guide for men who ... by up to 50 pounds in within a few ... that will help keep their shoulders healthy and avoid the ... the Critical Bench Program 2.0 uncovers to learners the reason ...
(Date:7/30/2014)... July 30, 2014 pMD, the ... communication, launched an Observation Result (ORU) interface to ... pMD’s cardiology customers are using the ORU interface ... their test interpretations for electrocardiograms, echocardiograms, and stress ... the hospital, the cardiology system produces electronic data ...
(Date:7/29/2014)... 2014 VisitandCare.com today announced ... added to the company’s exclusive network to help couples ... joint efforts — as top fertility clinics in Spain, ... affordable, state-of-the-art, and successful IVF treatments. , The exclusive ... comprehensive study by professionals at VisitandCare.com. The goal is ...
(Date:7/29/2014)... Phytceramides are a natural anti-aging tool for improving skin, and ... Today is the last day to nab a free download copy ... book is also sold in hard copy. , "I am working ... were so new and very unknown in the U.S. that ... Kathy Heshelow, founder of Sublime Beauty®. "It is an easy yet ...
(Date:7/29/2014)... 2014 The Mesothelioma Applied Research ... Cancer Coalition, led advocacy efforts among its members ... established Congressional Caucus on the Deadliest Cancers. , ... features the following 20 members: , Rep. Matt Salmon (AZ-5) ... 2, 2014, Rep. Zoe Lofgren (CA-19) – June 19, 2014, ...
Breaking Medicine News(10 mins):Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 3Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 3Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 2Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 3
... Clinicians to Overcome the Limitations of Conventional Pulse Oximetry, ... Calif., June 3 Masimo, the inventor of Pulse ... announced it has completed the conversion of Duke ... , , "Ultimately, the decision to convert ...
... ... for Christian Community. Christian Care Ministry, Inc. is a not-for-profit religious organization that facilitates ... ... 2009 -- Medi-Share is a member-based program where members share in each ...
... Genetics is pleased to announce the launch of whole-genome ... Oligo Array, which is designed to identify chromosomal abnormalities ... partnership with Baylor College of Medicine , Ambry ... comprehensive, clinically-validated genetic tests available using array comparative genomic ...
... Lauded in Healthcare Category for ,Visionary Application of Information ... , , MADISON, N.J., June 3 ... world,s leading provider of diagnostic testing, information and services, ... Ltd. has been recognized as a Laureate by the ...
... , WASHINGTON, June 3 New questions and valuable answers ... at www.tenquestionstoanswer.org , the latest in the Heinz Family Philanthropies ... designed to help families make the best long-term care decisions. Available ... manage long-term care. , , "We want ...
... STAMFORD, Conn., June 3 FUJIFILM Medical Systems ... today that the company has taken several steps ... company is already an experienced virtualization provider with ... successfully implemented across the U.S. Now, to ...
Cached Medicine News:Health News:Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry 2Health News:Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry 3Health News:Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry 4Health News:Medi-Share Program Announces New Healthcare Program Offerings for Christian Community 2Health News:'Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis' 2Health News:'Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis' 3Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 2Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 3Health News:Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program 4Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 2Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 3Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 4Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 5Health News:Fujifilm Takes Virtualization Technology to Next Level 2Health News:Fujifilm Takes Virtualization Technology to Next Level 3
(Date:7/29/2014)... -- Cynosure, Inc. (Nasdaq: CYNO ... treatment systems for high-volume applications, today reported financial results ... 2014 financial results incorporate the acquisition of Palomar Medical ... Second-Quarter 2014 Financial Highlights ... , Non-GAAP net income of $7.1 million, or ...
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... , July 29, 2014  Drug development for ... rising incidence rates and the intense need for ... vaccine. Change is underway as the market moves ... highly effective, easily-tolerated, interferon-free oral therapies. ... Gilead,s mega blockbuster Sovaldi is the first ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of 16,300,000 shares of ... per share to the public. The gross proceeds to ... $130,400,000, before deducting underwriting discounts and commissions, and other ...
... 26, 2011 American Scientific Resources, Inc. (OTCQB: ASFX) ... and Sanomedics International Holdings, Inc., and its affiliates, have ... United States District Court for the Southern District of ... judge, Hon. Ursula Ungaro, and the case has been ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit 2
... The new Guidant VASOVIEW® HemoPro™ ... deliver a new level of ... for both the saphenous vein ... cut-and-seal capability, it lets you ...
Patient Monitor...
...
... or antepartum GBS results can be available in ... revolutionary in vitro diagnostic test is the first ... in the clinical lab and near-patient by non-laboratory ... 24 hours a day, 365 days a year. ...
Medicine Products: